🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the free time to disease progressio...
Status
Completed
Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Start Date
2006-07
Trial ID
NCT00335595
This observational study will evaluate the efficacy and safety of bevacizum...
Status
Completed
Location
Clinique Esquirol Saint Hilaire
Start Date
2010-09-30
Trial ID
NCT01343901
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocki...
Status
Terminated
Location
University of Michigan Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00438204
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04148898
Treatments Being Tested
For patients with metastatic gastric cancer, the efficacy of current standa...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2024-11-14
Trial ID
NCT06711471
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested